Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Ppublish 11 citations
PubMed: 36469767 DOI: 10.1073/pnas.2202938119
A polyvalent multiepitope protein cross-protects against infection in rabbit colonization and passive protection models.
Proc Natl Acad Sci U S A 119(50):e2202938119
Authors: Ipshita Upadhyay, Siqi Li, Galen Ptacek, Hyesuk Seo, David A Sack, Weiping Zhang
Affiliations
- Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802.
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205.
Abstract
Using epitope- and structure-based multiepitope fusion antigen vaccinology platform, we constructed a polyvalent protein immunogen that presents antigenic domains (epitopes) of toxin-coregulated pilus A, cholera toxin (CT), sialidase, hemolysin A, flagellins (B, C, and D), and peptides mimicking lipopolysaccharide O-antigen on a flagellin B backbone. Mice and rabbits immunized intramuscularly with this polyvalent protein immunogen developed antibodies to all of the virulence factors targeted by the immunogen except lipopolysaccharide. Mouse and rabbit antibodies exhibited functional activities against CT enterotoxicity, CT binding to GM ganglioside, bacterial motility, and in vitro adherence of O1, O139, and non-O1/non-O139 serogroup strains. When challenged orogastrically with O1 El Tor N16961 or a non-O1/non-O139 strain, rabbits IM immunized with the immunogen showed a 2-log (99%) reduction in colonization of small intestines. Moreover, infant rabbits born to the mother immunized with the protein immunogen acquired antibodies passively and were protected from bacterial intestinal colonization (>2-log reduction), severe diarrhea (100%), and mild diarrhea (88%) after infection with O1 El Tor (N16961), O1 classical (O395), O139 (Bengal), or a non-O1/non-O139 strain. This study demonstrated that this polyvalent cholera protein is broadly immunogenic and cross-protective, and an adult rabbit colonization model and an infant rabbit passive protection model fill a gap in preclinical efficacy assessment in cholera vaccine development.
MeSH
Flagellin, Epitopes, Vaccines, Antibodies, Cholera, Diarrhea, Lipopolysaccharides, Infections, Infant
Cited by
- Adjuvants for vaccines: Outer membrane vesicles provide an alternative strategy. Virulence, 2024
- Heterologous prime-boost immunization of two-component vaccine candidate PWDVax protected pigs against F18 enterotoxigenic Escherichia coli post-weaning diarrhea. Infect Immun, 2025
- Polyvalent Protein Adhesin MEFA-II Induces Functional Antibodies against Enterotoxigenic Escherichia coli (ETEC) Adhesins CS7, CS12, CS14, CS17, and CS21 and Heat-Stable Toxin (STa). Appl Environ Microbiol, 2023
- Protein-based vaccine candidate MecVax broadly protects against enterotoxigenic intestinal colonization in a rabbit model. Infect Immun, 2023
- A chimeric protein-based vaccine elicits a strong IgG antibody response and confers partial protection against Shiga toxin-producing in mice. Front Immunol, 2023
- A Polyvalent Adhesin-Toxoid Multiepitope-Fusion-Antigen-Induced Functional Antibodies against Five Enterotoxigenic Adhesins (CS7, CS12, CS14, CS17, and CS21) but Not Enterotoxins (LT and STa). Microorganisms, 2023
- Immunogenicity and preclinical efficacy characterization of ShecVax, a combined vaccine against Shigella and enterotoxigenic Escherichia coli. Infect Immun, 2025